Profil Usia dan Pekerjaan Pasien Kanker Payudara NST berdasarkan Fenotipe Molekuler Her-2
DOI:
https://doi.org/10.31101/jhes.2324Abstract views 512 times
Keywords:
Her-2, kanker payudara, pekerjaan, usiaAbstract
References
Anders, C. K., Johnson, R., Litton, J., Phillips, M., Archie, B. (2010). Breast Cancer before Age 40 Years. Semin Oncol. 1-24. 2010
Allen P, (2016). “Age Categories and Life Cycle Groupings – Statistics Canada,†2016.
Anggorowati, L. (2013).Faktor Risiko Kanker Payudara Wanita. Kemas. 2: 102-8
Assi, H. A., Khoury, K. E., Dbouk, H., Khalil, L. E., Mouhieddine, T. H., El Saghir, N. S. (2010). Epidemiology and Prognosis of Breast Cancer in Young Women. J Thorac Dis. 5: 1-7. 2013
Balekouzou, A., Yin, P., Afewerky, H. K., Bekolo, C., Pamatika, C. M., Nambei, S. W. (2017). Behavioral Risk Factors of Breast Cancer in Bangui of Central African Republic: a Retrospektif Case-control Study. PLoS ONE. 1-16. 2017
Bray F, Ferlay J, Soerjomataram I, Siegel R, torre L, Jemal A. (2018).Global Cancer Statistics 2018. American Cancer Society Journals. September 2018
Brophy, J. T., Keith, M. M., Watterson, A., Park, R., Gilbertson, M., Maticka-Tyndale, E. (2012). Breast Cancer Risk in Relation to Occupations with Exposure to Carcinogens and Endocrine Disruptors: a Canadian Case-control. Environ Health. 1-17. 2012
Cancer Research. (2016). Breast Cancer. UK. 1-3. 2016.
Damodaran, S., Olson, E. M. (2013).Targeting the Human Epidermal Growth Factor 2 Pathway in Breast Cancer. Hosp Pract. 1-14. 2013
Data Riset Kesehatan Dasar. (2015). Stop Kanker. Badan Litbangkes Kementerian Kesehatan RI.
Dewi, G. A. T, Hendra, L. Y. (2015). Analisis Risiko Kanker Payudara Berdasar Riwayat Pemakaian Kontrasepsi Hormonal dan Usia Menarche. JBE. 3(1) : 12-23.
Fenga, C. (2016). Occupational Exposure and Risk of Breast Cancer (Review). Biomed Rep. 4: 282-92.
Gardstein B. M., K. Rokho dan L. K. Davis. (2003). “Occupation as a Risk Factor for Breast Cancer among Women in Massachusetts 1982-1992,â€. 2003
Ghani L, (2009). “Seluk Beluk Menopause,†Media Penelit. dan Pengembang. Kesehat., vol. 19, pp. 193-7, 2009.
Global Facts and Figures.(2015). American Cancer Society. 3rd edition. America.
Hatem, S. F., Alyaqubi, K. J., Al-Atrooshi, S. A., Alsayyid, M. M., Saad, M., Safaa, (2016). R. The Study of HER-2/neu, ER/PR Expression Using Immunohistochemistry (IHC) in the Iraqi Breast Cancer. J Vet Met Sci. 7: 18-27. 2016
Hutagalung, S. B., Mulyadi, I. K., Artha, I.G (2014). Ekspresi Ki-67 dan HER-2/neu Berhubungan dengan Derajat Histopatologik Kanker Payudara Invasive No Special Type (NST). Indones J Pathol. 23: 45-50.
Iqbal, N., Iqbal, N. (2014). Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications. Mol Biol Int. 1-10. 2014
Irwan, Azamris, Bachtiar, H. (2015). Perbandingan Prognosis Subtipe Molekuler Kanker Payudara antara Pasien Kanker Payudara Wanita Usia Muda dan Tua di RSUP Dr. M. Djamil Padang. MKA. 38: 208-17. 2015
Karima, U. Q., Wahyono, T. Y. (2013). Faktor-Faktor yang Berhubungan dengan Kejadian Kanker Payudara Wanita di Rumah Sakit Umum Pusat Nasional (RSUPN) Dr. Cipto Mangunkusumo Jakarta tahun 2013. 1-20.
Kullberg, C., Selander, J., Albin, M., Borgquist, S., Manjer, J., Gustavsson, P. (2017). Female White-collar Workers Remain at Higher Risk of breast Cancer after Adjustments for Individual Risk Factors Related to Reproduction and Lifestyle. Occup Environ Med. 1-7. 2017
Kurniati YP, Amarwati S, Sadhana U, Puspasari D. (2017). Gambaran Histopatologi Ekspresi Interferon Gamma (ᵧ) pada Fibroadenoma Mammae (FAM) dan Invasive No Special Type (NST) Breast Carcinoma. Biomedika vol 9 No 2.
Kurniati YP and Putri MP. (2019). The Molecular Phenotype Of Human Epidermal Growth Factor Receptor2 Java Ethnic Based On Body Mass Index In Breast cancer. International Conference on Pharmaceutical Updates.
Labellapansa, A., Muhimmah, I., Indrayanti. (2013). Klasifikasi Citra Imunohistokimia Sel Kanker Payudara HER2 Skore 1+ dan 3+. SNIMed. 24-30. 2013
Laamiri, F. Z., Bouayad, A., Hasswane, N., Ahid, S., Mrabet, M., Amina B. (2015). Risk Factors for Breast Cancer of Different Age Groups: Moroccan Data?. OJOG. 5: 79-87. 2015
Liu, Y., Zhang, J., Huang, R.,Feng, W., Kong, Y., Xu, F., Zhao, L., Shong, Q. (2017). Influence of Occupation and Education Level on Breast Cancer Stage at Diagnosis, and Treatment
Lumintang, L. M., Susanto, A., Gadri, R.. (2015). Djatmiko, A. Profil Pasien Kanker Payudara di Rumah Sakit Onkologi Surabaya, 2014. Indones J Cancer. 105-10.
Manik, N. T., Maryati, I., Ermiati. (2012). Riwayat Gaya Hidup Penderita Kanker Payudara di Rumah Sakit Umum Daerah Kota Sumedang. 1-16. 2012
Moasser, M. M. (2011).The Oncogen Her2; its Signaling and Transforming Functions and its Role in Human Cancer Pathogenesis. Oncogene. 1-32. 2011
Mukti, A. F. R., Bekti, R. S., Roebijoso, J. (2016). Korelasi Pemeriksaan Human Epidermal Growth Factor Receptor-2 (HER-2) denga Stadium Klinis TNM pada Pasien Kanker Payudaradi Instalasi Patologi Anatomi RS dr. Saiful Anwar Periode Januari 2010-Desember 2012. Majalah Kesehatan FKUB. 3: 112-120. 2016
Nani, D. (2009). Analisis Faktor-Faktor yang Berhubungan dengan Kejadian Kanker Payudara di Rumah Sakit Pertamina Cilacap. JKS. 61-6. 2009
Norsa'adah, B., Rampal. K. G.,Rahmah, M. A., Naing, N. N., Biswal, B. M. (2011). Diagnosis Delay of Breast Cancer and Its Associated Factors in Malaysian Women. BMC Cancer. 11: 1-8. 2011
Pranjic, N., Gledo, I., Males-Bilic, L. (2014). The Most Common New Cases of Breast Cancer among the Housewives: The SomeCarcinogenic Determinant. 7(2): 344-349. 2014
Price, S. A., Wilson, L. M. (2005). Patofisiologi: Konsep Klinis Proses-Proses Penyakit. 6th edition. Jakarta: EGC. 2005
Priyatin, C., Ulfiana, E., Sumarni, S. (2013). Faktor Risiko yang Berpengaruh terhadap Kejadian Kanker Payudara di RSUP Dr. Kariadi Semarang. JK. 9-19. 2013
Purwanto, I., Kurnianda, J., Hariadi, K. W., Harijadi, Aryandono, T., Setiaji, K. (2011) Concentration of Serum HER-2/Neu as a Prognostic Factor in Locally Advanced Breast Cancer (LABC) and Metastatic Breast Cancer (MBC). Indones J Intern Med. 23-8. 2011
Rahmatya, A., Khambri, D., Mulyani, H. (2015). Hubungan Usia dengan Gambaran Klinikopatologi Kanker Payudara di Bagian Bedah Dr. M. Djamil Padang. JKA. 478-84. 2015option in China. Med. 1-9. 2017
Rimawi, M. F., Shetty, P. B., Weiss, H. L., Schiff, R., Osbome, C. K., Chamness, G. C.(2010). Epidermal Growth Factor Receptor Expression in Breast Cancer Association with Biologic Phenotype and Clinical Outcomes. Cancer. 1234-42.
Robbins, Kumar. (2015). Pathologic Basic of Disease. 9th edition. Philadelphi: Saunders, Elsevier. 2015.
Romadhon, Y.A. (2013). Gangguan Siklus Sel dan Mutasi Gen pada Kanker Payudara. CDK. 10: 786-9.
Rosai, J. Rosai and Ackerman's Surgical Pathology. 10th edition.Philadelphia: Saunders, Elsevier. 2011
Samsiah. (2016). Faktor-Faktor yang Mempengaruhi Penguasaan Aspek Bilangan pada Guru SD Negeri di Kecamatan Pangkajene Kabupaten Pangkep. Sainsmat. 5: 125-36. 2016
Santer., Siregar, K.B., Suyatno. (2013). Profil Ekspresi HER2 dan Ki67 pada Berbagai Kelompok Usia Penderita Kanker Payudara di RSUP H. Adam Malik Medan. J Med Sch. 46(3) : 1-4.
Statistics South Africa.Census 2001: Stages in the Life Cycle of South Africans. Africa. 2005
Sulistiyowati. (2012). Stadium Kanker Payudara Ditinjau dari Usia dan Paritas Ibu di Unit Rawat Jalan RSUD Dr. Soegiri Kabupaten Lamongan. 3(13) : 9-15.
Tai, W., Mahato, R., Cheng, K. (2011). The Role of HER2 in Cancer Therapy and Targetes Drug Delivery. J Control Release. 1-28. 2011
Upadana, I. N., Artha, I. G. (2014). Hubungan Ekspresi Cyclooxygenase-2, Reseptor Estrogen dan Derajat Histologi Invasive Carcinoma of No Special Type Payudara. Indones J Pathol. 6-10. 2014
Wei, R., Lau. S. S. S., Cheung, P. S. Y. (2010). Breast Carcinoma in Chinese Women: Does Age Affect Treatment Choice and Outcome?. Asian J Surg. 33 (2): 97-102. 2010
Wen, D., He, Y., Wei, L., Zhang,N., Li,S., Wen, X., Yang, Y., Wang, G., Wang,S., Geng,C., Liu,Y., Shan,B. (2016). Incidance Rate of Female Breast Cancer in Urban Shijiazhuang in 2012 and Modifiable Risk Factors. Thor Cancer. 7: 522-529. 2016
Wijaya, I. G. C. P., Manuaba, I. B. T. W. (2014). Hubungan Subtipe Imunohistokimia dengan Usia pada Pasien Kanker Payudara di RSUP Sanglah Kota Denpasar. E-Jurnal Medika. 6: 1-5. 2017
WHO. (2012). Classification of Tumours of the Breast. 4th edition. Lyon.
Yan B, L.-M. Yang, L.-P. Hao, C. Yang, L. Quan, L.-H. Wang, Z. Wu, X.-P. Li, Y.-T. Gao, Q. Sun dan J.-M. Yuan, (2016). “Determinants of Quality of Life for Breast Cancer Patients in Shanghai, China,†2016.
Zaha D. C. (2014). “Significance of immunohistochemistry in breast cancer,†World J Clin Oncol, pp. 382-91. 2014
Downloads
Published
Issue
Section
License
With the receipt of the article by the Journal of Health Studies Editorial Board and the decision to be published, then the copyright regarding the article will be diverted to Journal of Health Studies. Universitas 'Aisyiyah Yogyakarta as the publisher of Journal of Health Studies hold the copyright regarding all the published articles in this journal.
Journal of Health Studies is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
